Advancing hepatic recompensation:Baveno VII criteria and therapeutic innovations in liver cirrhosis management  

作　　者：Lorenzo Ridola Sara Del Cioppo 

机构地区：[1]Department of Medical and Surgical Sciences and Biotechnologies,Sapienza University of Rome,Polo Pontino,Rome 00185,Italy

出　　处：《World Journal of Gastroenterology》2024年第23期2954-2958,共5页世界胃肠病学杂志（英文版）

摘　　要：The Baveno VII criteria redefine the management of decompensated liver cirrhosis,introducing the concept of hepatic recompensation marking a significant departure from the conventional view of irreversible decline.Central to this concept is addressing the underlying cause of cirrhosis through tailored therapies,including antivirals and lifestyle modifications.Studies on alcohol,hepatitis C virus,and hepatitis B virus-related cirrhosis demonstrate the efficacy of these interventions in improving liver function and patient outcomes.Transjugular intrahepatic portosystemic shunt(TIPS)emerges as a promising intervention,effectively resolving complications of portal hypertension and facilitating recompensation.However,optimal timing and patient selection for TIPS remain unresolved.Despite challenges,TIPS offers renewed hope for hepatic recompensation,marking a significant advancement in cirrhosis management.Further research is needed to refine its implementation and maximize its benefits.In conclusion,TIPS stands as a promising avenue for improving hepatic function and patient outcomes in decompensated liver cirrhosis within the framework of the Baveno VII criteria.

关 键 词：Hepatic recompensation Baveno VII Transjugular intrahepatic portosystemic shunt Portal hypertension Cirrhosis DECOMPENSATION 

分 类 号：R575.2[医药卫生—消化系统]